Eupraxia Pharmaceuticals Inc. share price logo

Eupraxia Pharmaceuticals Inc.

NASDAQ: EPRX

Small Cap

$6.60

+0.01

(+0.15%)

as on

Eupraxia Pharmaceuticals Inc. Stock Performance

as on July 1, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $6.42
    $6.71
    downward going graph

    2.73%

    Downside

    1.67%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.88
    $9.32
    downward going graph

    26.06%

    Downside

    41.21%

    Upside

    downward going graph

Eupraxia Pharmaceuticals Inc. share price movements today

Previous Close
$6.59
Open
$6.58
Volume
686.1K
Day's Low - High
$6.42 - $6.71
52 Week Low - High
$4.88 - $9.32

Eupraxia Pharmaceuticals Inc. Historical Returns

1 Month Return
-7.05 %
3 Month Return
-0.3 %
1 Year Return
+ 14.41 %
3 Year Return
0 %
5 Year Return
0 %

Eupraxia Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Eupraxia Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$431.2M

EPS (TTM)

-0.975

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-47.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-54.52%

Eupraxia Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eupraxia Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Eupraxia Pharmaceuticals Inc. image
Eupraxia Pharmaceuticals Inc.
BUY$431.2MNANA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$38.7B506.87%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$38.9B73.15%73.0312.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$124.7B147.81%29.1635.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$66.4B13.12%15.4629.65%0.58%

Stock Returns calculator for Eupraxia Pharmaceuticals Inc. Stock including INR - Dollar returns

The Eupraxia Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Eupraxia Pharmaceuticals Inc. investment value today

Current value as on today

₹1,26,563

Returns

₹26,563

(+26.56%)

Returns from Eupraxia Pharmaceuticals Inc. Stock

₹14,583 (+14.58%)

Dollar Impact

₹11,980 (+11.98%)

Analyst Recommendation on Eupraxia Pharmaceuticals Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Eupraxia Pharmaceuticals Inc.. Average target price of $16.28

Eupraxia Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Eupraxia Pharmaceuticals Inc..

What analysts predicted

59.46%UPSIDE

Target Price

$16.28

Current Price

$6.6

Analyzed by

8 Analysts

Target

$16.28

Eupraxia Pharmaceuticals Inc. target price $16.28, a slight upside of 59.46% compared to current price of $6.6. According to 8 analysts rating.

Indian Investors' Interest in Eupraxia Pharmaceuticals Inc. Stock

Search interest for Eupraxia Pharmaceuticals Inc. Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:11% versus previous 30 day period

Eupraxia Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
2
2
-
-
-
-
-
-
-
-
Gross Profit
0
1
0
0
0
-
-
0
0
0
Operating Income
-6
-4
-6
-6
-7
-7
-8
-4
-16
-15
EBITDA
-4
-4
-5
-5
-7
-6
-8
-4
-16
-15
Interest Expense
0
0
0
0
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-4
-6
-5
-7
-6
-8
-4
-16
-12
Income Tax Expense
0
0
0
-
0
0
0
0
0
0
Net Income
-3
-3
-6
-5
-7
-6
-8
-4
-16
-12
Net Profit Margin
-158.49%
-149.39%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Eupraxia Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
Operating Income
-2
-14
-17
-20
-26
-53
EBITDA
-2
-17
-17
-20
-24
-53
Interest Expense
1
1
0
0
0
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-4
-18
-18
-21
-25
-53
Income Tax Expense
1
-1
0
0
0
0
Net Income
-4
-18
-18
-21
-25
-53
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Eupraxia Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-4
-4
-4
-7
-6
-8
-4
-16
-12
Operating Cash Flow
-4
-5
-7
-5
-6
-8
-3
-9
-10
Investing Cash Flow
0
0
0
0
0
0
0
0
-78
Financing Cash Flow
17
-3
-3
31
0
0
52
1
67
Change in Cash
12
-9
-10
24
-5
-7
49
-8
-21

Eupraxia Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-14
-7
-3
-18
-18
-21
-25
-39
Operating Cash Flow
-8
-5
0
-11
-14
-15
-29
-29
Investing Cash Flow
0
-1
0
-11
9
0
0
0
Financing Cash Flow
5
7
0
39
10
15
45
77
Change in Cash
-3
0
-1
16
5
0
13
47

Global Institutional Holdings in Eupraxia Pharmaceuticals Inc.

Funds
Holdings
Affinity Asset Advisors, LLC
2.43%
Redmile Group, LLC
1.07%
Aisling Capital Management LP
0.53%
Alyeska Investment Group, L.P.
0.57%
Vivo Capital, LLC
2.07%
See all

Eupraxia Pharmaceuticals Inc. News & Key Events

  • img

    Today's Timeline - 20 February

    Sat, 01:40 AM

    -

    Eupraxia Pharmaceuticals closes US$63.2 million public offering, expanding pipeline and advancing clinical trials for EP-104GI.

Insights on Eupraxia Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, EPRX stock has moved up by 3.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 423.6% return, outperforming this stock by 409.2%

About Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
OrganisationEupraxia Pharmaceuticals Inc.
Headquarters2067 Cadboro Bay Road, Victoria, BC, Canada, V8R 5G4
IndustryBiotechnology
CEODr. James A. Helliwell FRCPC, M.D.
E-voting on sharesClick here to vote

Key Management of Eupraxia Pharmaceuticals Inc.

Name

Title

Mr. Paul Anthony Brennan B.Sc., M.Sc.

Chief Corporate Development Officer

Dr. James A. Helliwell FRCPC, M.D.

CEO & Director

Mr. Alexander John Rothwell Eng., M.B.A.

Chief Financial Officer

Dr. Amanda Malone Ph.D.

Chief Scientific Officer & COO

FAQs

What is Eupraxia Pharmaceuticals Inc. share price today?

Eupraxia Pharmaceuticals Inc. share price today is $6.6 as on at the close of the market. Eupraxia Pharmaceuticals Inc. share today touched a day high of $6.71 and a low of $6.42.

What is the 52 week high and 52 week low for Eupraxia Pharmaceuticals Inc. share?

Eupraxia Pharmaceuticals Inc. share touched a 52 week high of $9.32 on and a 52 week low of $4.88 on . Eupraxia Pharmaceuticals Inc. stock price today i.e. is closed at $6.6,which is 29.18% down from its 52 week high and 35.25% up from its 52 week low.

What is Eupraxia Pharmaceuticals Inc.'s market capitalisation today?

Eupraxia Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in Eupraxia Pharmaceuticals Inc. Stock (EPRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Eupraxia Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eupraxia Pharmaceuticals Inc. Shares that will get you 0.2273 shares as per Eupraxia Pharmaceuticals Inc. share price of $6.6 per share as on July 1, 2026 at 1:29 am IST.

What is the minimum amount required to buy Eupraxia Pharmaceuticals Inc. Stock (EPRX) from India?

Indian investors can start investing in Eupraxia Pharmaceuticals Inc. (EPRX) shares with as little as ₹94.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.60 in Eupraxia Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Eupraxia Pharmaceuticals Inc. share’s latest price of $6.6 as on July 1, 2026 at 1:29 am IST, you will get 1.5152 shares of Eupraxia Pharmaceuticals Inc.. Learn more about fractional shares .